Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point they rarely leave their home and are unable to work and build meaningful ...

Patience E Obiweluozo, Ibiwari C Dike, Francisca N Ogba, Chinyere O Elom, Florence O Orabueze, Stella Okoye-Ugwu, Casmir KC Ani, Augustine O Onu, Victor Ukaogo, Loveline N Obayi, Sunday E Abonyi, ...

Alzamend aims to predict minimum dose necessary to achieve the equivalent effectiveness and safety of AL001 versus other lithium salts. Lithium was the first mood stabilizer approved by the FDA and is ...

ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for ...

PALM BEACH, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Worldwide, there is a rising demand for neuropsychiatric disorder treatments which is expected to fuel the global ...

There is evidence that the CBD compound in cannabis may help treat some anxiety disorders, though research is limited.